Pfizer Sues Ranbaxy, Teva Over Accupril Patent

Law360 (February 21, 2005, 12:00 AM EST) -- Pfizer Inc. has sued India’s Ranbaxy and Israel’s Teva Pharmaceuticals in New Jersey federal court, alleging that the two companies are infringing a process patent for the hypertension drug Accupril.

The lawsuit, filed in late January in the U.S. District Court for the District of New Jersey, alleges that Ranbaxy infringes a process patent held by Parke-Davis, which was later acquired by Pfizer.

Ranbaxy's generic version reaches the U.S. market under Teva’s label through a supply agreement between the two companies.

Teva was granted six-month marketing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.